462 filings
Page 6 of 24
6-K
qbxu 4ppxzw
29 Jun 22
Current report (foreign)
6:27am
6-K
bbrmog jbqlwb6
27 Jun 22
HUTCHMED to Announce 2022 Half-Year Financial Results
6:20am
CORRESP
8pt59m
8 Jun 22
Correspondence with SEC
12:00am
6-K
wyeuh9vxu4tv
1 Jun 22
HUTCHMED Announces TAZVERIK® Approved to be Used in Hainan Pilot Zone in China
6:25am
UPLOAD
x52volmc
26 May 22
Letter from SEC
12:00am
6-K
o5i5e00r36p6xrh
24 May 22
Grant of Awards under Long Term Incentive Plan and Share Options under Share Option Scheme
6:22am
6-K
fvdwb4x 1m
16 May 22
Appointment of Non–Executive Director
7:24am
6-K
4c0ezah
2 May 22
Current report (foreign)
6:57am
6-K
9kv aro25
27 Apr 22
Current report (foreign)
9:33am
6-K
o67jom8x03ifnwl78ll
21 Apr 22
Vesting of awards under the Long Term Incentive Plan
6:40am
6-K
oydoc aiakb0
31 Mar 22
Update on Status under Holding Foreign Companies Accountable Act
6:26am
6-K
gk9vr79sjjgw3q
23 Mar 22
2021 Annual Report and Notice of Annual General Meeting
6:35am
6-K
1pdi ycvap27bv73
11 Mar 22
Update on Status under Holding Foreign Companies Accountable Act
6:16am
6-K
2db17kx
9 Mar 22
Vesting of awards under the Long Term Incentive Plan
6:43am
6-K
45lgrcy76na1i
7 Mar 22
Current report (foreign)
6:19am
6-K
ncmnpinh
3 Mar 22
HUTCHMED Reports 2021 Full Year Results and Provides Business Updates
9:00am
6-K
eu6bl09 a6625
3 Mar 22
HUTCHMED announces retirement of CEO
8:36am
6-K
n81s awqvngruqp9h
1 Mar 22
HUTCHMED Receives Approval to Commercialize ELUNATE® in Macau
6:37am
6-K
22rvdxd2
7 Feb 22
HUTCHMED to Announce 2021 Final Results
6:12am